NEA 12 GP, LLC's Net Worth

$1.16 Billion

Estimate Recalculated Aug 28, 2024 06:02PM EST

Who is NEA 12 GP, LLC?

NEA 12 GP, LLC has an estimated net worth of $1.16 Billion. This is based on reported shares across multiple companies, which include OPOWER, INC., Workday, Inc., Echo Global Logistics, Inc., FUSION-IO, INC., TriVascular Technologies, Inc., HYPERION THERAPEUTICS INC, CHANNELADVISOR CORP, Groupon, Inc., Zosano Pharma Corp, Tintri, Inc., TREVENA INC, PROTEOSTASIS THERAPEUTICS, INC., ARDELYX, INC., SUNESIS PHARMACEUTICALS INC, Liquidia Technologies Inc, PEPLIN INC, ARYx Therapeutics, Inc., and HEMOSENSE INC.

SEC CIK

NEA 12 GP, LLC's CIK is 0001383389

Past Insider Trading and Trends

2012 was NEA 12 GP, LLC's most active year for acquiring shares with 25 total transactions. NEA 12 GP, LLC's most active month to acquire stocks was the month of January. 2014 was NEA 12 GP, LLC's most active year for disposing of shares, totalling 35 transactions. NEA 12 GP, LLC's most active month to dispose stocks was the month of January. 2015 saw NEA 12 GP, LLC paying a total of $23,518,351.15 for 2,794,565 shares, this is the most they've acquired in one year. In 2015 NEA 12 GP, LLC cashed out on 2,384,221 shares for a total of $109,674,166.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

SUNESIS PHARMACEUTICALS INC (VIRX) Snapshot price: $0.5601

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-5.41%
-266.70K
$7.97
-$2,126,726.84
4.66M
Aug 27 - Aug 29
Form 4
-12.61%
-710.54K
$6.63
-$4,708,757.48
4.93M
Aug 8 - Aug 12
Form 4
∞
33.82M
$0.28
—
33.82M
Jun 30
Form 4
—
0
—
—
0
Oct 30
Form 3
—
0
—
—
0
No matching records found

PEPLIN INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-1.30M
$16.99
-$22,117,268.53
0
Nov 11
Form 4
+1.18%
15.22K
$0.49
$7,457.09
1.3M
Mar 10 - Mar 11
Form 3
—
0
—
—
0
No matching records found

ARYx Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-4.47M
$0.07
-$326,257.00
0
Mar 10
Form 3
—
0
—
—
0
No matching records found

HEMOSENSE INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

OPOWER, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-8.99M
$10.30
-$92,594,589.80
0
Jun 14
Form 4
∞
8.99M
—
—
8.99M
Apr 9
Form 3
—
0
—
—
0
No matching records found